Quote:
Originally Posted by Tyrone Slothrop
I'm old enough to remember way back when Sebby was talking up the benefits of Trump's wonder drug for Covid-19.
WaPo
Funny how they have to write the press release as if Trump is going to read it -- "no longer reasonable," as if it ever was.
|
I wasn't wrong. Nor was Icky, who knew people saved all but assuredly by the drug.
This disease won't be fully understood for a long time and the criteria on which this FDA opinion was offered might include the fact that other drugs are as effective but potentially less risky.
A victory lap on any therapy based on what the FDA says is wildly premature.
ETA: Here's the exact FDA language:
On June 15, 2020, based on FDA’s continued review of the scientific evidence available for hydroxychloroquine sulfate (HCQ) and chloroquine phosphate (CQ) to treat COVID-19, FDA has determined that the statutory criteria for EUA as outlined in Section 564(c)(2) of the Food, Drug, and Cosmetic Act are no longer met. Specifically, FDA has determined that CQ and HCQ are unlikely to be effective in treating COVID-19 for the authorized uses in the EUA. Additionally, in light of ongoing serious cardiac adverse events and other serious side effects, the known and potential benefits of CQ and HCQ no longer outweigh the known and potential risks for the authorized use. This warrants revocation of the EUA for HCQ and CQ for the treatment of COVID-19.
CQ has caused heart issues. That's why HCQ was developed (it causes far fewer). Nevertheless, the FDA lumps them together, as though they have identical cardiac impacts.
The other consideration is, we can't tease out how many patients with covid given HCQ had heart issues because of the drug versus the disease. We're just now beginning to understand that this is a blood disease more than respiratory one.